Project
Illumina Body Map 2
Navigation
Downloads
Results for BPTF
Z-value: 2.05
Motif logo
Transcription factors associated with BPTF
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
BPTF
|
ENSG00000171634.12 | bromodomain PHD finger transcription factor |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| BPTF | hg19_v2_chr17_+_65821636_65821641 | 0.13 | 4.6e-01 | Click! |
Activity profile of BPTF motif
Sorted Z-values of BPTF motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_-_55653259 | 3.19 |
ENST00000593194.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
| chr12_-_111358372 | 3.18 |
ENST00000548438.1
ENST00000228841.8 |
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow |
| chr10_-_61513201 | 3.10 |
ENST00000414264.1
ENST00000594536.1 |
LINC00948
|
long intergenic non-protein coding RNA 948 |
| chrX_-_15332665 | 3.08 |
ENST00000537676.1
ENST00000344384.4 |
ASB11
|
ankyrin repeat and SOCS box containing 11 |
| chr6_+_53976211 | 2.99 |
ENST00000503951.1
|
MLIP
|
muscular LMNA-interacting protein |
| chr17_-_10452929 | 2.92 |
ENST00000532183.2
ENST00000397183.2 ENST00000420805.1 |
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult |
| chr3_-_196242233 | 2.83 |
ENST00000397537.2
|
SMCO1
|
single-pass membrane protein with coiled-coil domains 1 |
| chr10_-_61513146 | 2.68 |
ENST00000430431.1
|
LINC00948
|
long intergenic non-protein coding RNA 948 |
| chr7_-_150329421 | 2.67 |
ENST00000493969.1
ENST00000328902.5 |
GIMAP6
|
GTPase, IMAP family member 6 |
| chr6_+_53976235 | 2.57 |
ENST00000502396.1
ENST00000358276.5 |
MLIP
|
muscular LMNA-interacting protein |
| chr12_-_70093111 | 2.53 |
ENST00000548658.1
ENST00000476098.1 ENST00000331471.4 ENST00000393365.1 |
BEST3
|
bestrophin 3 |
| chr3_+_35681728 | 2.42 |
ENST00000421492.1
ENST00000458225.1 ENST00000337271.5 |
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
| chr5_+_82767583 | 2.32 |
ENST00000512590.2
ENST00000513960.1 ENST00000513984.1 ENST00000502527.2 |
VCAN
|
versican |
| chr6_+_53976285 | 2.30 |
ENST00000514433.1
|
MLIP
|
muscular LMNA-interacting protein |
| chr6_+_31691121 | 2.26 |
ENST00000480039.1
ENST00000375810.4 ENST00000375805.2 ENST00000375809.3 ENST00000375804.2 ENST00000375814.3 ENST00000375806.2 |
C6orf25
|
chromosome 6 open reading frame 25 |
| chr10_-_115423792 | 2.25 |
ENST00000369360.3
ENST00000360478.3 ENST00000359988.3 ENST00000369358.4 |
NRAP
|
nebulin-related anchoring protein |
| chr2_-_32489922 | 2.25 |
ENST00000402280.1
|
NLRC4
|
NLR family, CARD domain containing 4 |
| chr7_+_28725585 | 2.21 |
ENST00000396298.2
|
CREB5
|
cAMP responsive element binding protein 5 |
| chr4_-_44653636 | 2.20 |
ENST00000415895.4
ENST00000332990.5 |
YIPF7
|
Yip1 domain family, member 7 |
| chr1_-_119530428 | 2.14 |
ENST00000369429.3
|
TBX15
|
T-box 15 |
| chr10_-_1071796 | 2.12 |
ENST00000277517.1
|
IDI2
|
isopentenyl-diphosphate delta isomerase 2 |
| chr19_-_14785622 | 2.08 |
ENST00000443157.2
|
EMR3
|
egf-like module containing, mucin-like, hormone receptor-like 3 |
| chr6_+_106535455 | 2.02 |
ENST00000424894.1
|
PRDM1
|
PR domain containing 1, with ZNF domain |
| chr19_-_14889349 | 1.97 |
ENST00000315576.3
ENST00000392967.2 ENST00000346057.1 ENST00000353876.1 ENST00000353005.1 |
EMR2
|
egf-like module containing, mucin-like, hormone receptor-like 2 |
| chr9_+_108424738 | 1.97 |
ENST00000334077.3
|
TAL2
|
T-cell acute lymphocytic leukemia 2 |
| chr19_-_14785698 | 1.95 |
ENST00000344373.4
ENST00000595472.1 |
EMR3
|
egf-like module containing, mucin-like, hormone receptor-like 3 |
| chr12_+_101988627 | 1.94 |
ENST00000547405.1
ENST00000452455.2 ENST00000441232.1 ENST00000360610.2 ENST00000392934.3 ENST00000547509.1 ENST00000361685.2 ENST00000549145.1 ENST00000553190.1 |
MYBPC1
|
myosin binding protein C, slow type |
| chr6_+_42749759 | 1.94 |
ENST00000314073.5
|
GLTSCR1L
|
GLTSCR1-like |
| chr16_-_2007607 | 1.92 |
ENST00000565426.1
|
RPL3L
|
ribosomal protein L3-like |
| chr17_+_67498295 | 1.91 |
ENST00000589295.1
|
MAP2K6
|
mitogen-activated protein kinase kinase 6 |
| chr19_-_14785674 | 1.91 |
ENST00000253673.5
|
EMR3
|
egf-like module containing, mucin-like, hormone receptor-like 3 |
| chr12_-_10282681 | 1.89 |
ENST00000533022.1
|
CLEC7A
|
C-type lectin domain family 7, member A |
| chr12_-_719573 | 1.88 |
ENST00000397265.3
|
NINJ2
|
ninjurin 2 |
| chr12_-_122884553 | 1.88 |
ENST00000535290.1
|
CLIP1
|
CAP-GLY domain containing linker protein 1 |
| chr12_-_54689532 | 1.86 |
ENST00000540264.2
ENST00000312156.4 |
NFE2
|
nuclear factor, erythroid 2 |
| chr1_-_24438664 | 1.84 |
ENST00000374434.3
ENST00000330966.7 ENST00000329601.7 |
MYOM3
|
myomesin 3 |
| chrX_+_15767971 | 1.83 |
ENST00000479740.1
ENST00000454127.2 |
CA5B
|
carbonic anhydrase VB, mitochondrial |
| chr4_-_74847800 | 1.80 |
ENST00000296029.3
|
PF4
|
platelet factor 4 |
| chr17_-_10450866 | 1.80 |
ENST00000578017.1
|
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult |
| chr5_-_55224569 | 1.78 |
ENST00000595799.1
|
AC008914.1
|
Uncharacterized protein |
| chr12_+_101988774 | 1.78 |
ENST00000545503.2
ENST00000536007.1 ENST00000541119.1 ENST00000361466.2 ENST00000551300.1 ENST00000550270.1 |
MYBPC1
|
myosin binding protein C, slow type |
| chr2_+_28718921 | 1.75 |
ENST00000327757.5
ENST00000422425.2 ENST00000404858.1 |
PLB1
|
phospholipase B1 |
| chr6_+_37897735 | 1.75 |
ENST00000373389.5
|
ZFAND3
|
zinc finger, AN1-type domain 3 |
| chr6_-_123958141 | 1.74 |
ENST00000334268.4
|
TRDN
|
triadin |
| chr16_+_21623958 | 1.74 |
ENST00000568826.1
|
METTL9
|
methyltransferase like 9 |
| chr8_-_17942432 | 1.74 |
ENST00000381733.4
ENST00000314146.10 |
ASAH1
|
N-acylsphingosine amidohydrolase (acid ceramidase) 1 |
| chr9_+_137298396 | 1.72 |
ENST00000540193.1
|
RXRA
|
retinoid X receptor, alpha |
| chr6_-_123957942 | 1.70 |
ENST00000398178.3
|
TRDN
|
triadin |
| chr8_+_134029937 | 1.70 |
ENST00000518108.1
|
TG
|
thyroglobulin |
| chr7_+_44663908 | 1.68 |
ENST00000543843.1
|
OGDH
|
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
| chr1_-_159684371 | 1.65 |
ENST00000255030.5
ENST00000437342.1 ENST00000368112.1 ENST00000368111.1 ENST00000368110.1 ENST00000343919.2 |
CRP
|
C-reactive protein, pentraxin-related |
| chr19_-_54824344 | 1.62 |
ENST00000346508.3
ENST00000446712.3 ENST00000432233.3 ENST00000301219.3 |
LILRA5
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 |
| chrX_-_30877837 | 1.61 |
ENST00000378930.3
|
TAB3
|
TGF-beta activated kinase 1/MAP3K7 binding protein 3 |
| chr13_-_114843416 | 1.60 |
ENST00000389544.4
|
RASA3
|
RAS p21 protein activator 3 |
| chr10_-_16563870 | 1.60 |
ENST00000298943.3
|
C1QL3
|
complement component 1, q subcomponent-like 3 |
| chr3_+_187461442 | 1.60 |
ENST00000450760.1
|
RP11-211G3.2
|
RP11-211G3.2 |
| chr16_+_30387141 | 1.58 |
ENST00000566955.1
|
MYLPF
|
myosin light chain, phosphorylatable, fast skeletal muscle |
| chr12_-_70093190 | 1.57 |
ENST00000330891.5
|
BEST3
|
bestrophin 3 |
| chr17_-_5321549 | 1.57 |
ENST00000572809.1
|
NUP88
|
nucleoporin 88kDa |
| chr6_-_15548591 | 1.56 |
ENST00000509674.1
|
DTNBP1
|
dystrobrevin binding protein 1 |
| chr7_+_76054224 | 1.56 |
ENST00000394857.3
|
ZP3
|
zona pellucida glycoprotein 3 (sperm receptor) |
| chr5_-_171404730 | 1.56 |
ENST00000518752.1
|
FBXW11
|
F-box and WD repeat domain containing 11 |
| chr6_-_123958051 | 1.56 |
ENST00000546248.1
|
TRDN
|
triadin |
| chr1_-_27952741 | 1.56 |
ENST00000399173.1
|
FGR
|
feline Gardner-Rasheed sarcoma viral oncogene homolog |
| chr17_+_72595971 | 1.55 |
ENST00000581412.1
|
CTD-2006K23.1
|
CTD-2006K23.1 |
| chr17_+_4855053 | 1.54 |
ENST00000518175.1
|
ENO3
|
enolase 3 (beta, muscle) |
| chr8_-_57472154 | 1.54 |
ENST00000499425.1
ENST00000523664.1 ENST00000518943.1 ENST00000524338.1 |
LINC00968
|
long intergenic non-protein coding RNA 968 |
| chr8_-_41655107 | 1.54 |
ENST00000347528.4
ENST00000289734.7 ENST00000379758.2 ENST00000396945.1 ENST00000396942.1 ENST00000352337.4 |
ANK1
|
ankyrin 1, erythrocytic |
| chr11_-_47546250 | 1.53 |
ENST00000543178.1
|
CELF1
|
CUGBP, Elav-like family member 1 |
| chr3_-_194119995 | 1.52 |
ENST00000323007.3
|
GP5
|
glycoprotein V (platelet) |
| chr9_+_75766652 | 1.52 |
ENST00000257497.6
|
ANXA1
|
annexin A1 |
| chr5_+_36608280 | 1.51 |
ENST00000513646.1
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
| chr12_-_57644952 | 1.51 |
ENST00000554578.1
ENST00000546246.2 ENST00000553489.1 ENST00000332782.2 |
STAC3
|
SH3 and cysteine rich domain 3 |
| chr16_+_7560114 | 1.51 |
ENST00000570626.1
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
| chr13_+_50202435 | 1.50 |
ENST00000282026.1
|
ARL11
|
ADP-ribosylation factor-like 11 |
| chr1_+_10290822 | 1.50 |
ENST00000377083.1
|
KIF1B
|
kinesin family member 1B |
| chr3_+_154741907 | 1.48 |
ENST00000492661.1
|
MME
|
membrane metallo-endopeptidase |
| chr17_+_57807062 | 1.48 |
ENST00000587259.1
|
VMP1
|
vacuole membrane protein 1 |
| chr12_-_70093162 | 1.47 |
ENST00000551160.1
|
BEST3
|
bestrophin 3 |
| chr11_-_47546220 | 1.47 |
ENST00000528538.1
|
CELF1
|
CUGBP, Elav-like family member 1 |
| chr6_-_123958111 | 1.46 |
ENST00000542443.1
|
TRDN
|
triadin |
| chr16_-_4039001 | 1.46 |
ENST00000576936.1
|
ADCY9
|
adenylate cyclase 9 |
| chr4_-_38806404 | 1.45 |
ENST00000308979.2
ENST00000505940.1 ENST00000515861.1 |
TLR1
|
toll-like receptor 1 |
| chr16_+_2106134 | 1.45 |
ENST00000467949.1
|
TSC2
|
tuberous sclerosis 2 |
| chr5_-_58882219 | 1.44 |
ENST00000505453.1
ENST00000360047.5 |
PDE4D
|
phosphodiesterase 4D, cAMP-specific |
| chr12_+_10124110 | 1.43 |
ENST00000350667.4
|
CLEC12A
|
C-type lectin domain family 12, member A |
| chr4_+_170581213 | 1.43 |
ENST00000507875.1
|
CLCN3
|
chloride channel, voltage-sensitive 3 |
| chr4_-_114438763 | 1.42 |
ENST00000509594.1
|
CAMK2D
|
calcium/calmodulin-dependent protein kinase II delta |
| chr19_+_50936142 | 1.42 |
ENST00000357701.5
|
MYBPC2
|
myosin binding protein C, fast type |
| chr3_+_154801678 | 1.41 |
ENST00000462837.1
|
MME
|
membrane metallo-endopeptidase |
| chr17_-_72527605 | 1.41 |
ENST00000392621.1
ENST00000314401.3 |
CD300LB
|
CD300 molecule-like family member b |
| chr15_+_66585555 | 1.40 |
ENST00000319194.5
ENST00000525134.2 ENST00000441424.2 |
DIS3L
|
DIS3 mitotic control homolog (S. cerevisiae)-like |
| chr12_-_8693469 | 1.40 |
ENST00000545274.1
ENST00000446457.2 |
CLEC4E
|
C-type lectin domain family 4, member E |
| chr18_-_74839891 | 1.39 |
ENST00000581878.1
|
MBP
|
myelin basic protein |
| chr5_+_96294145 | 1.38 |
ENST00000395770.3
|
LNPEP
|
leucyl/cystinyl aminopeptidase |
| chr6_+_140175987 | 1.38 |
ENST00000414038.1
ENST00000431609.1 |
RP5-899B16.1
|
RP5-899B16.1 |
| chr18_-_67615088 | 1.38 |
ENST00000582621.1
|
CD226
|
CD226 molecule |
| chr9_+_75766763 | 1.38 |
ENST00000456643.1
ENST00000415424.1 |
ANXA1
|
annexin A1 |
| chr18_-_56296182 | 1.37 |
ENST00000361673.3
|
ALPK2
|
alpha-kinase 2 |
| chr8_-_66750978 | 1.37 |
ENST00000523253.1
|
PDE7A
|
phosphodiesterase 7A |
| chr5_-_59481406 | 1.37 |
ENST00000546160.1
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific |
| chr3_+_171757346 | 1.37 |
ENST00000421757.1
ENST00000415807.2 ENST00000392699.1 |
FNDC3B
|
fibronectin type III domain containing 3B |
| chr5_+_55147205 | 1.36 |
ENST00000396836.2
ENST00000396834.1 ENST00000447346.2 ENST00000359040.5 |
IL31RA
|
interleukin 31 receptor A |
| chr1_+_167599330 | 1.35 |
ENST00000367854.3
ENST00000361496.3 |
RCSD1
|
RCSD domain containing 1 |
| chr17_+_57287228 | 1.35 |
ENST00000578922.1
ENST00000300917.5 |
SMG8
|
SMG8 nonsense mediated mRNA decay factor |
| chr4_-_159080806 | 1.34 |
ENST00000590648.1
|
FAM198B
|
family with sequence similarity 198, member B |
| chr11_-_73693875 | 1.34 |
ENST00000536983.1
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
| chr1_+_212968025 | 1.33 |
ENST00000530399.2
|
TATDN3
|
TatD DNase domain containing 3 |
| chr2_+_219246746 | 1.33 |
ENST00000233202.6
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1 |
| chr3_-_196987309 | 1.32 |
ENST00000453607.1
|
DLG1
|
discs, large homolog 1 (Drosophila) |
| chr1_+_10292308 | 1.32 |
ENST00000377081.1
|
KIF1B
|
kinesin family member 1B |
| chr21_+_45366811 | 1.32 |
ENST00000398058.1
ENST00000457068.1 ENST00000448845.1 |
AGPAT3
|
1-acylglycerol-3-phosphate O-acyltransferase 3 |
| chr18_+_61575200 | 1.31 |
ENST00000238508.3
|
SERPINB10
|
serpin peptidase inhibitor, clade B (ovalbumin), member 10 |
| chr16_+_30386098 | 1.31 |
ENST00000322861.7
|
MYLPF
|
myosin light chain, phosphorylatable, fast skeletal muscle |
| chr12_-_70093235 | 1.30 |
ENST00000266661.4
|
BEST3
|
bestrophin 3 |
| chr14_+_56127960 | 1.30 |
ENST00000553624.1
|
KTN1
|
kinectin 1 (kinesin receptor) |
| chr1_-_119532127 | 1.30 |
ENST00000207157.3
|
TBX15
|
T-box 15 |
| chr4_-_85771168 | 1.30 |
ENST00000514071.1
|
WDFY3
|
WD repeat and FYVE domain containing 3 |
| chr14_+_73563735 | 1.29 |
ENST00000532192.1
|
RBM25
|
RNA binding motif protein 25 |
| chr19_+_42055879 | 1.29 |
ENST00000407170.2
ENST00000601116.1 ENST00000595395.1 |
CEACAM21
AC006129.2
|
carcinoembryonic antigen-related cell adhesion molecule 21 AC006129.2 |
| chr8_+_23430157 | 1.28 |
ENST00000399967.3
|
FP15737
|
FP15737 |
| chr4_+_57845024 | 1.28 |
ENST00000431623.2
ENST00000441246.2 |
POLR2B
|
polymerase (RNA) II (DNA directed) polypeptide B, 140kDa |
| chr12_+_8666126 | 1.28 |
ENST00000299665.2
|
CLEC4D
|
C-type lectin domain family 4, member D |
| chr12_-_111142729 | 1.27 |
ENST00000546713.1
|
HVCN1
|
hydrogen voltage-gated channel 1 |
| chr14_-_89878369 | 1.27 |
ENST00000553840.1
ENST00000556916.1 |
FOXN3
|
forkhead box N3 |
| chr1_-_9563433 | 1.26 |
ENST00000441033.1
|
RP13-392I16.1
|
RP13-392I16.1 |
| chr17_-_7080227 | 1.26 |
ENST00000574330.1
|
ASGR1
|
asialoglycoprotein receptor 1 |
| chr1_+_36335351 | 1.26 |
ENST00000373206.1
|
AGO1
|
argonaute RISC catalytic component 1 |
| chr6_+_42584847 | 1.25 |
ENST00000372883.3
|
UBR2
|
ubiquitin protein ligase E3 component n-recognin 2 |
| chr2_+_168043793 | 1.25 |
ENST00000409273.1
ENST00000409605.1 |
XIRP2
|
xin actin-binding repeat containing 2 |
| chr17_+_67410832 | 1.25 |
ENST00000590474.1
|
MAP2K6
|
mitogen-activated protein kinase kinase 6 |
| chr2_+_1417228 | 1.25 |
ENST00000382269.3
ENST00000337415.3 ENST00000345913.4 ENST00000346956.3 ENST00000349624.3 ENST00000539820.1 ENST00000329066.4 ENST00000382201.3 |
TPO
|
thyroid peroxidase |
| chr1_-_27952617 | 1.25 |
ENST00000457296.1
|
FGR
|
feline Gardner-Rasheed sarcoma viral oncogene homolog |
| chr10_-_6622201 | 1.24 |
ENST00000539722.1
ENST00000397176.2 |
PRKCQ
|
protein kinase C, theta |
| chr14_+_39734482 | 1.23 |
ENST00000554392.1
ENST00000555716.1 ENST00000341749.3 ENST00000557038.1 |
CTAGE5
|
CTAGE family, member 5 |
| chr6_-_139613269 | 1.23 |
ENST00000358430.3
|
TXLNB
|
taxilin beta |
| chr6_+_150690028 | 1.23 |
ENST00000229447.5
ENST00000344419.3 |
IYD
|
iodotyrosine deiodinase |
| chr4_+_57845043 | 1.21 |
ENST00000433463.1
ENST00000314595.5 |
POLR2B
|
polymerase (RNA) II (DNA directed) polypeptide B, 140kDa |
| chr17_-_65242063 | 1.21 |
ENST00000581159.1
|
HELZ
|
helicase with zinc finger |
| chr14_+_22963806 | 1.20 |
ENST00000390493.1
|
TRAJ44
|
T cell receptor alpha joining 44 |
| chr10_-_6622258 | 1.20 |
ENST00000263125.5
|
PRKCQ
|
protein kinase C, theta |
| chr17_-_9683238 | 1.19 |
ENST00000571771.1
|
DHRS7C
|
dehydrogenase/reductase (SDR family) member 7C |
| chr7_+_95115210 | 1.18 |
ENST00000428113.1
ENST00000325885.5 |
ASB4
|
ankyrin repeat and SOCS box containing 4 |
| chr1_+_9299895 | 1.18 |
ENST00000602477.1
|
H6PD
|
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
| chr5_+_82767487 | 1.18 |
ENST00000343200.5
ENST00000342785.4 |
VCAN
|
versican |
| chr3_+_152017924 | 1.18 |
ENST00000465907.2
ENST00000492948.1 ENST00000485509.1 ENST00000464596.1 |
MBNL1
|
muscleblind-like splicing regulator 1 |
| chr19_-_45996465 | 1.18 |
ENST00000430715.2
|
RTN2
|
reticulon 2 |
| chr6_+_4773205 | 1.18 |
ENST00000440139.1
|
CDYL
|
chromodomain protein, Y-like |
| chr6_+_150690133 | 1.18 |
ENST00000392255.3
ENST00000500320.3 |
IYD
|
iodotyrosine deiodinase |
| chr15_+_55611128 | 1.17 |
ENST00000164305.5
ENST00000539642.1 |
PIGB
|
phosphatidylinositol glycan anchor biosynthesis, class B |
| chr3_-_71777824 | 1.16 |
ENST00000469524.1
|
EIF4E3
|
eukaryotic translation initiation factor 4E family member 3 |
| chr14_+_22931924 | 1.16 |
ENST00000390477.2
|
TRDC
|
T cell receptor delta constant |
| chr17_+_66521936 | 1.16 |
ENST00000592800.1
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha |
| chrX_-_1656000 | 1.16 |
ENST00000381297.4
|
P2RY8
|
purinergic receptor P2Y, G-protein coupled, 8 |
| chr1_-_45452240 | 1.16 |
ENST00000372183.3
ENST00000372182.4 ENST00000360403.2 |
EIF2B3
|
eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa |
| chr21_-_46330545 | 1.16 |
ENST00000320216.6
ENST00000397852.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr22_+_44427230 | 1.15 |
ENST00000444029.1
|
PARVB
|
parvin, beta |
| chr1_-_161207986 | 1.15 |
ENST00000506209.1
ENST00000367980.2 |
NR1I3
|
nuclear receptor subfamily 1, group I, member 3 |
| chr19_-_7764281 | 1.14 |
ENST00000360067.4
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23) |
| chr11_+_46383121 | 1.14 |
ENST00000454345.1
|
DGKZ
|
diacylglycerol kinase, zeta |
| chrY_+_2709906 | 1.14 |
ENST00000430575.1
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1 |
| chr17_-_295730 | 1.14 |
ENST00000329099.4
|
FAM101B
|
family with sequence similarity 101, member B |
| chr8_-_90993869 | 1.14 |
ENST00000517772.1
|
NBN
|
nibrin |
| chr11_-_82745238 | 1.14 |
ENST00000531021.1
|
RAB30
|
RAB30, member RAS oncogene family |
| chr8_-_57472049 | 1.13 |
ENST00000523786.1
ENST00000521483.1 |
LINC00968
|
long intergenic non-protein coding RNA 968 |
| chr17_+_4699439 | 1.12 |
ENST00000270586.3
|
PSMB6
|
proteasome (prosome, macropain) subunit, beta type, 6 |
| chr1_-_11042094 | 1.12 |
ENST00000377004.4
ENST00000377008.4 |
C1orf127
|
chromosome 1 open reading frame 127 |
| chr8_-_126963487 | 1.11 |
ENST00000518964.1
|
LINC00861
|
long intergenic non-protein coding RNA 861 |
| chr7_+_110731062 | 1.10 |
ENST00000308478.5
ENST00000451085.1 ENST00000422987.3 ENST00000421101.1 |
LRRN3
|
leucine rich repeat neuronal 3 |
| chrX_-_55020511 | 1.09 |
ENST00000375006.3
ENST00000374992.2 |
PFKFB1
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
| chr3_+_46395219 | 1.08 |
ENST00000445132.2
ENST00000292301.4 |
CCR2
|
chemokine (C-C motif) receptor 2 |
| chr19_+_8483272 | 1.08 |
ENST00000602117.1
|
MARCH2
|
membrane-associated ring finger (C3HC4) 2, E3 ubiquitin protein ligase |
| chr16_-_28621353 | 1.08 |
ENST00000567512.1
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
| chr3_+_151591422 | 1.08 |
ENST00000362032.5
|
SUCNR1
|
succinate receptor 1 |
| chr3_-_135916073 | 1.08 |
ENST00000481989.1
|
MSL2
|
male-specific lethal 2 homolog (Drosophila) |
| chr17_+_26638667 | 1.07 |
ENST00000600595.1
|
AC061975.10
|
Uncharacterized protein |
| chr12_-_25150373 | 1.07 |
ENST00000549828.1
|
C12orf77
|
chromosome 12 open reading frame 77 |
| chr17_-_66287310 | 1.07 |
ENST00000582867.1
|
SLC16A6
|
solute carrier family 16, member 6 |
| chr2_-_179537145 | 1.07 |
ENST00000448510.2
|
TTN
|
titin |
| chr6_+_144904334 | 1.07 |
ENST00000367526.4
|
UTRN
|
utrophin |
| chr19_+_45457834 | 1.07 |
ENST00000546079.1
ENST00000541297.2 |
CLPTM1
|
cleft lip and palate associated transmembrane protein 1 |
| chr10_-_10504285 | 1.07 |
ENST00000602311.1
|
RP11-271F18.4
|
RP11-271F18.4 |
| chr10_+_47894023 | 1.07 |
ENST00000358474.5
|
FAM21B
|
family with sequence similarity 21, member B |
| chr10_+_90521163 | 1.06 |
ENST00000404459.1
|
LIPN
|
lipase, family member N |
| chr9_-_117692697 | 1.06 |
ENST00000223795.2
|
TNFSF8
|
tumor necrosis factor (ligand) superfamily, member 8 |
| chr7_+_80267949 | 1.06 |
ENST00000482059.2
|
CD36
|
CD36 molecule (thrombospondin receptor) |
| chr5_+_137203541 | 1.06 |
ENST00000421631.2
|
MYOT
|
myotilin |
| chr1_+_40810516 | 1.05 |
ENST00000435168.2
|
SMAP2
|
small ArfGAP2 |
| chr3_-_47950745 | 1.05 |
ENST00000429422.1
|
MAP4
|
microtubule-associated protein 4 |
| chr9_-_27573651 | 1.05 |
ENST00000379995.1
ENST00000379997.3 |
C9orf72
|
chromosome 9 open reading frame 72 |
| chr5_-_96143602 | 1.05 |
ENST00000443439.2
ENST00000503921.1 ENST00000508227.1 ENST00000507154.1 |
ERAP1
|
endoplasmic reticulum aminopeptidase 1 |
| chr10_-_94003003 | 1.05 |
ENST00000412050.4
|
CPEB3
|
cytoplasmic polyadenylation element binding protein 3 |
| chr1_+_66458072 | 1.05 |
ENST00000423207.2
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific |
| chr11_+_63273547 | 1.05 |
ENST00000255684.5
ENST00000394618.3 |
LGALS12
|
lectin, galactoside-binding, soluble, 12 |
| chr1_-_28503693 | 1.05 |
ENST00000373857.3
|
PTAFR
|
platelet-activating factor receptor |
| chr11_-_46113756 | 1.04 |
ENST00000531959.1
|
PHF21A
|
PHD finger protein 21A |
| chrX_+_149887090 | 1.04 |
ENST00000538506.1
|
MTMR1
|
myotubularin related protein 1 |
| chr15_+_55611401 | 1.03 |
ENST00000566999.1
|
PIGB
|
phosphatidylinositol glycan anchor biosynthesis, class B |
| chr3_+_35682913 | 1.03 |
ENST00000449196.1
|
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
| chr5_+_137203557 | 1.03 |
ENST00000515645.1
|
MYOT
|
myotilin |
Network of associatons between targets according to the STRING database.
First level regulatory network of BPTF
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.6 | 6.5 | GO:1901846 | positive regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901846) |
| 1.0 | 2.9 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.9 | 4.7 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 0.8 | 3.1 | GO:1904647 | response to rotenone(GO:1904647) |
| 0.7 | 2.1 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
| 0.7 | 2.0 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
| 0.6 | 2.4 | GO:2000569 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.6 | 1.8 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) |
| 0.6 | 1.7 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
| 0.5 | 3.3 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
| 0.5 | 2.1 | GO:0050993 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.5 | 1.6 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 0.5 | 1.9 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.5 | 0.5 | GO:0002819 | regulation of adaptive immune response(GO:0002819) |
| 0.5 | 1.4 | GO:2000458 | astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
| 0.4 | 1.3 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
| 0.4 | 4.8 | GO:2000332 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
| 0.4 | 1.3 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.4 | 1.7 | GO:0052419 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 0.4 | 1.2 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.4 | 1.6 | GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 0.4 | 8.8 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.4 | 0.8 | GO:0048769 | sarcomerogenesis(GO:0048769) |
| 0.4 | 2.0 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 0.4 | 2.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.4 | 2.3 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
| 0.4 | 4.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.4 | 1.5 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.4 | 0.7 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
| 0.4 | 3.2 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.4 | 1.8 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.3 | 1.0 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.3 | 1.0 | GO:1902565 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 0.3 | 1.7 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.3 | 2.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.3 | 0.3 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.3 | 1.0 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.3 | 1.0 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 0.3 | 3.2 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.3 | 2.3 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.3 | 0.9 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 0.3 | 0.6 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.3 | 3.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.3 | 1.5 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
| 0.3 | 1.8 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
| 0.3 | 1.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.3 | 1.8 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.3 | 1.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.3 | 2.3 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.3 | 1.7 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.3 | 2.7 | GO:0019050 | suppression by virus of host apoptotic process(GO:0019050) modulation by virus of host apoptotic process(GO:0039526) |
| 0.3 | 0.8 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.3 | 0.8 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
| 0.3 | 0.5 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.3 | 1.0 | GO:0032208 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
| 0.3 | 1.3 | GO:1901536 | negative regulation of DNA demethylation(GO:1901536) |
| 0.3 | 4.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.3 | 1.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.2 | 1.2 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.2 | 1.2 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.2 | 0.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.2 | 2.6 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.2 | 3.6 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
| 0.2 | 0.7 | GO:0042245 | RNA repair(GO:0042245) |
| 0.2 | 1.6 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.2 | 1.4 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.2 | 0.7 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.2 | 0.9 | GO:1904799 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.2 | 1.4 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.2 | 0.5 | GO:2000662 | interleukin-5 secretion(GO:0072603) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) |
| 0.2 | 0.9 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.2 | 0.7 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 0.2 | 0.7 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.2 | 0.9 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 | 1.3 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
| 0.2 | 0.7 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.2 | 0.9 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.2 | 1.3 | GO:0001757 | somite specification(GO:0001757) |
| 0.2 | 3.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.2 | 3.0 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.2 | 0.8 | GO:1901143 | insulin catabolic process(GO:1901143) |
| 0.2 | 0.6 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.2 | 1.0 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.2 | 2.7 | GO:0046449 | creatinine metabolic process(GO:0046449) |
| 0.2 | 0.6 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.2 | 1.2 | GO:1904383 | response to sodium phosphate(GO:1904383) |
| 0.2 | 0.6 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 0.2 | 1.4 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.2 | 0.6 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.2 | 1.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.2 | 1.8 | GO:0030242 | pexophagy(GO:0030242) |
| 0.2 | 2.4 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.2 | 0.6 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.2 | 0.6 | GO:0046495 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.2 | 1.2 | GO:0018032 | protein amidation(GO:0018032) |
| 0.2 | 0.8 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.2 | 1.0 | GO:1990535 | neuron projection maintenance(GO:1990535) |
| 0.2 | 1.0 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.2 | 1.6 | GO:0072642 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.2 | 1.4 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 0.2 | 0.8 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.2 | 0.6 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
| 0.2 | 1.9 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
| 0.2 | 0.8 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.2 | 1.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.2 | 0.8 | GO:0051598 | meiotic recombination checkpoint(GO:0051598) |
| 0.2 | 0.2 | GO:2000426 | negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.2 | 0.7 | GO:0006549 | isoleucine metabolic process(GO:0006549) isoleucine catabolic process(GO:0006550) |
| 0.2 | 1.1 | GO:0006064 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.2 | 0.4 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.2 | 0.6 | GO:0002584 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
| 0.2 | 1.1 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
| 0.2 | 1.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.2 | 0.7 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.2 | 1.4 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 0.2 | 0.5 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
| 0.2 | 1.3 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.2 | 1.6 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.2 | 1.6 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.2 | 4.1 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
| 0.2 | 2.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.2 | 0.9 | GO:2000690 | regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.2 | 1.7 | GO:0071988 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.2 | 0.7 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.2 | 0.5 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.2 | 0.2 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.2 | 0.9 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.2 | 0.2 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.2 | 1.9 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.2 | 1.5 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.2 | 0.8 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.2 | 1.0 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.2 | 3.6 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
| 0.2 | 0.5 | GO:2000473 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
| 0.2 | 1.3 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 0.2 | 0.5 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.2 | 0.3 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.2 | 1.3 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.2 | 0.5 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.2 | 0.7 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 0.2 | 0.6 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.2 | 0.5 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.2 | 0.8 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.2 | 0.8 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.2 | 0.6 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
| 0.2 | 1.0 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.2 | 0.5 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.2 | 1.6 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
| 0.2 | 0.9 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.2 | 0.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
| 0.2 | 0.8 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.2 | 0.5 | GO:0030578 | PML body organization(GO:0030578) |
| 0.2 | 0.9 | GO:1902617 | response to fluoride(GO:1902617) |
| 0.2 | 1.6 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.2 | 1.4 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.2 | 0.3 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
| 0.2 | 4.3 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.2 | 1.4 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.2 | 0.6 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.2 | 1.4 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.2 | 0.9 | GO:0019427 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.2 | 1.1 | GO:0032916 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.2 | 1.8 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
| 0.1 | 0.7 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.1 | 0.6 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
| 0.1 | 0.6 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.1 | 0.3 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.1 | 3.4 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.1 | 3.4 | GO:0014870 | response to muscle inactivity(GO:0014870) |
| 0.1 | 0.3 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 0.1 | 1.2 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.1 | 3.2 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 | 1.0 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
| 0.1 | 0.6 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.1 | 1.2 | GO:0060844 | arterial endothelial cell fate commitment(GO:0060844) positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
| 0.1 | 1.2 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.1 | 1.3 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.1 | 3.6 | GO:0016246 | RNA interference(GO:0016246) |
| 0.1 | 0.9 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.1 | 0.4 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 0.1 | 2.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 | 0.3 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
| 0.1 | 0.6 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.1 | 2.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 | 2.8 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.1 | 1.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 | 0.6 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
| 0.1 | 0.7 | GO:0035711 | T-helper 1 cell activation(GO:0035711) |
| 0.1 | 6.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 0.7 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.1 | 0.7 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.1 | 1.0 | GO:0048286 | lung alveolus development(GO:0048286) |
| 0.1 | 0.5 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
| 0.1 | 5.0 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
| 0.1 | 0.9 | GO:0060179 | courtship behavior(GO:0007619) male mating behavior(GO:0060179) |
| 0.1 | 0.8 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.1 | 0.4 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.1 | 0.7 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.1 | 0.8 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.1 | 0.6 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.1 | 0.4 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.1 | 0.8 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.1 | 0.4 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 | 1.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 | 0.3 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
| 0.1 | 3.6 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 | 0.8 | GO:0021993 | fourth ventricle development(GO:0021592) initiation of neural tube closure(GO:0021993) |
| 0.1 | 0.5 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.1 | 2.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.1 | 0.4 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.1 | 0.5 | GO:0002429 | immune response-activating cell surface receptor signaling pathway(GO:0002429) |
| 0.1 | 0.4 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
| 0.1 | 0.6 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 | 0.4 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 0.1 | 0.9 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 | 1.2 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 0.1 | 0.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.1 | 1.4 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.1 | 1.0 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
| 0.1 | 0.7 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.1 | 1.0 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.1 | 0.2 | GO:0036292 | DNA rewinding(GO:0036292) |
| 0.1 | 0.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.1 | 0.1 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.1 | 2.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.1 | 1.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 | 2.5 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.1 | 0.7 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.1 | 0.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.1 | 1.0 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.1 | 1.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 | 0.5 | GO:0048489 | synaptic vesicle transport(GO:0048489) establishment of synaptic vesicle localization(GO:0097480) |
| 0.1 | 0.3 | GO:0072616 | interleukin-18 secretion(GO:0072616) |
| 0.1 | 0.5 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.1 | 0.8 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.1 | 3.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 | 1.0 | GO:0071316 | cellular response to nicotine(GO:0071316) |
| 0.1 | 0.8 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
| 0.1 | 0.8 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.1 | 0.1 | GO:0050904 | diapedesis(GO:0050904) |
| 0.1 | 0.8 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
| 0.1 | 0.7 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 | 0.9 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
| 0.1 | 1.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 | 0.2 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
| 0.1 | 0.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.1 | 0.4 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.1 | 0.5 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.1 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 | 0.5 | GO:0006294 | nucleotide-excision repair, preincision complex assembly(GO:0006294) |
| 0.1 | 1.2 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
| 0.1 | 0.4 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.1 | 0.5 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.1 | 1.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.1 | 1.3 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
| 0.1 | 1.8 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
| 0.1 | 3.2 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.1 | 0.4 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.1 | 1.9 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.1 | 0.9 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.1 | 0.4 | GO:0098582 | innate vocalization behavior(GO:0098582) |
| 0.1 | 0.4 | GO:0051808 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.1 | 0.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
| 0.1 | 0.6 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
| 0.1 | 0.6 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 0.1 | 0.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.1 | 0.7 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
| 0.1 | 0.7 | GO:0097319 | fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.1 | 0.3 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.1 | 0.4 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.1 | 0.8 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.1 | 1.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 | 0.5 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.1 | 0.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.1 | 0.7 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.1 | 2.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.1 | 1.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 | 0.2 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.1 | 0.6 | GO:1900827 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.1 | 0.7 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.1 | 0.5 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.1 | 1.3 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 | 0.4 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.1 | 0.6 | GO:1902957 | negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
| 0.1 | 1.3 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.1 | 0.6 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 | 1.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 | 0.2 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 | 0.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.1 | 1.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
| 0.1 | 0.4 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.1 | 0.7 | GO:1904796 | regulation of core promoter binding(GO:1904796) |
| 0.1 | 0.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 | 0.6 | GO:0097205 | glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
| 0.1 | 0.4 | GO:0030473 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
| 0.1 | 0.3 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.1 | 0.5 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.1 | 0.4 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.1 | 0.5 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.1 | 0.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.1 | 0.7 | GO:0001878 | response to yeast(GO:0001878) |
| 0.1 | 0.6 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.1 | 1.6 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.1 | 0.4 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
| 0.1 | 0.3 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.1 | 0.3 | GO:1905203 | regulation of connective tissue replacement(GO:1905203) positive regulation of connective tissue replacement(GO:1905205) |
| 0.1 | 1.6 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
| 0.1 | 0.3 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.1 | 0.3 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.1 | 0.3 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.1 | 1.6 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
| 0.1 | 0.2 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.1 | 0.9 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.1 | 0.4 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.1 | 1.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.1 | 0.9 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.1 | 0.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.1 | 0.4 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.1 | 1.2 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
| 0.1 | 0.2 | GO:1903516 | regulation of single strand break repair(GO:1903516) |
| 0.1 | 0.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 | 0.3 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
| 0.1 | 4.5 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.1 | 0.2 | GO:0035568 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.1 | 0.3 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.1 | 1.0 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.1 | 0.4 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.1 | 0.3 | GO:2001176 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.1 | 0.7 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 | 1.0 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.1 | 0.7 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 | 0.7 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
| 0.1 | 2.1 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.1 | 1.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.1 | 1.2 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 | 0.2 | GO:0033967 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.1 | 1.0 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.1 | 0.9 | GO:0006999 | nuclear pore organization(GO:0006999) nuclear pore complex assembly(GO:0051292) |
| 0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
| 0.1 | 2.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 | 0.5 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.1 | 0.2 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.1 | 0.6 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.1 | 1.7 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.1 | 0.5 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.1 | 0.2 | GO:0072387 | flavin-containing compound biosynthetic process(GO:0042727) flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.1 | 0.6 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.1 | 0.8 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.1 | 0.5 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.1 | 0.3 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.1 | 0.3 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 | 0.5 | GO:0060356 | leucine import(GO:0060356) |
| 0.1 | 0.5 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
| 0.1 | 1.8 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.1 | 0.7 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 | 0.4 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 0.1 | 1.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 | 0.3 | GO:1903487 | regulation of lactation(GO:1903487) |
| 0.1 | 1.7 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.1 | 0.6 | GO:0061197 | fungiform papilla development(GO:0061196) fungiform papilla morphogenesis(GO:0061197) |
| 0.1 | 2.1 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
| 0.1 | 1.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.1 | 0.3 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
| 0.1 | 0.4 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 | 2.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.1 | 0.4 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.1 | 1.6 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
| 0.1 | 1.1 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
| 0.1 | 1.1 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.1 | 0.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 | 0.1 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 | 0.1 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 | 0.3 | GO:0010157 | response to chlorate(GO:0010157) |
| 0.1 | 0.3 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.1 | 0.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.1 | 0.4 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.1 | 0.7 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.1 | 1.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 | 0.3 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
| 0.1 | 0.5 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.1 | 0.4 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.1 | 0.8 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.1 | 0.3 | GO:0051255 | spindle midzone assembly(GO:0051255) |
| 0.1 | 0.5 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.1 | 0.5 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.1 | 1.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.1 | 0.2 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.1 | 1.0 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.1 | 0.6 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
| 0.1 | 0.2 | GO:0071338 | submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 0.1 | 0.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 | 3.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 | 0.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 | 4.0 | GO:0002292 | T cell differentiation involved in immune response(GO:0002292) |
| 0.1 | 0.6 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 | 3.2 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 | 0.8 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 0.1 | 1.4 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 0.1 | 0.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.1 | 0.5 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.1 | 0.2 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) |
| 0.1 | 0.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 | 0.8 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.1 | 0.4 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.1 | 2.4 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 0.1 | 0.4 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 | 0.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 | 1.5 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.1 | 0.7 | GO:1901299 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
| 0.1 | 2.4 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.1 | 0.4 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 | 0.2 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.1 | 0.8 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
| 0.1 | 0.8 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.1 | 3.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.1 | 5.7 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 | 0.2 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
| 0.1 | 0.2 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 | 1.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 | 0.5 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.1 | 0.3 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.1 | 0.3 | GO:1903593 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) regulation of histamine secretion by mast cell(GO:1903593) |
| 0.1 | 2.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.1 | 1.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 | 0.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
| 0.1 | 0.5 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.1 | 1.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.1 | 0.8 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
| 0.1 | 0.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.1 | 0.4 | GO:1904720 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.1 | 1.1 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.1 | 0.5 | GO:2000828 | post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.1 | 0.3 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.1 | 0.4 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 | 0.5 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.1 | 0.9 | GO:0039536 | negative regulation |